Paul Hudson has been CEO of Sanofi since September 2019. Previously, he was CEO of Novartis Pharmaceuticals from 2016 to 2019. Prior to Novartis, he worked for AstraZeneca, where he held several increasingly senior positions and served as president, AstraZeneca US and executive vice president, North America. He began his career in sales and marketing roles at GlaxoSmithKline UK and Sanofi-Synth?labo UK.
Australia and Canada signed a $1.75 billion export agreement on Monday to build an Australian-designed long-range radar system in Canada....
By now, everyone is probably aware of the massive daycare fraud scandal in Minnesota. But such corruption continues to be...
Israel’s biggest banks have already handed out almost two-thirds of the NIS 3 billion they committed to transfer to...
Silver (SI=F) July futures opened at $63.85 per ounce on Monday, 3.7% lower than Friday's closing price of $66.32. The...
The day of reckoning for Indonesia’s stock market is here. MSCI, the global benchmark provider, will determine whether to downgrade...
Archion Corporation, the new holding company for Japanese commercial vehicle manufacturers Mitsubishi Fuso Truck and Bus Corporation (MFTBC) and Hino...
The first and only national digital and print magazine that connects individuals, families, and businesses to Fee-Only financial advisers, accountants, attorneys and college guidance counselors.
-1024x683.jpg "Florida Roads Become a Battleground for Illegal Immigration")
